This inventor holds 4 USPTO granted patents. Top assignees: Henning Berlin Gmbh Chemie-Und Pharmawerk, B.r.a.h.m.s. Diagnostica Gmbh. Active years: 1984-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1997
Title: Hartmut Rokos: Innovator in Immunological Methods
Introduction
Hartmut Rokos is a distinguished inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly in the development of methods for the determination of free substances. With a total of four patents to his name, Rokos has focused on improving clinical practices through innovative solutions.
Latest Patents
Rokos's latest patents include "Pterin derivatives the preparation thereof and the use thereof" and "Immunological method for the determination of free substances having hapten properties." His work on immunological methods aims to enhance the routine clinical determination of free substances, especially free thyroid hormones. The new method simplifies the process and reduces errors associated with existing techniques. It introduces a reliable approach that contrasts previous assumptions regarding the affinity of immobilized substances and labelled antibodies.
Career Highlights
Throughout his career, Hartmut Rokos has worked with notable companies such as Henning Berlin GmbH Chemie-und Pharmawerk and B.R.A.H.M.S. Diagnostica GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to advancements in diagnostic methods.
Collaborations
Rokos has collaborated with esteemed colleagues, including Heinz Konczak and Wolfgang Forth. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hartmut Rokos stands out as a key figure in the field of immunology, with a focus on improving clinical determination methods. His patents and collaborations reflect his commitment to advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile